PULMONX CORPORATION (LUNG) Operating cash flow 2018–2025
PULMONX CORPORATION (LUNG) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$32.4MFY2025 · since FY2018: -$18.4M → -$32.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.4M | -2.7% |
| FY2024 | -$31.5M | +16.1% |
| FY2023 | -$37.6M | +16.6% |
| FY2022 | -$45.1M | -8.9% |
| FY2021 | -$41.4M | -35.1% |
| FY2020 | -$30.6M | -47.5% |
| FY2019 | -$20.8M | -12.9% |
| FY2018 | -$18.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net incomeLUNG Net marginLUNG Gross profitLUNG Gross marginLUNG Operating incomeLUNG Operating marginLUNG Free cash flowLUNG Capital expendituresLUNG Return on equityLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Total liabilitiesLUNG Shareholders’ equityLUNG overview →